Table 3 Patient demographics and lesion characteristics
From: MRI-guided in-bore biopsy of the prostate – defining the optimal number of cores needed
Negative (%) | GG1 (%) | ≥GG2 (%) | All (%) | |
|---|---|---|---|---|
N (lesions) N (patients) | 118 (47.2%) (113 pat. [46.1%]) | 68 (27.2%) (68 pat. [27.8%]) | 64 (25.6%) (64 pat. [26.1%]) | 250 (245 pat.) |
Age (mean ± SD, y) | 64.8 ± 8.4 | 67.0 ± 7.7 | 70.0 ± 7.0 | 66.8 ± 8.1 |
PSA (ng/ml) | 10.0 ± 9.5 | 9.1 ± 5.7 | 12.0 ± 13.6 | 10.3 ± 9.9 |
mpMRI PI-RADS: | ||||
PI-RADS Score 3 | 10.2% (12/118) | 4.4% (3/68) | 1.6% (1/64) | 6.4% (16/250) |
PI-RADS Score 4 | 71.2% (84/118) | 76.5% (52/68) | 65.6% (42/64) | 71.2% (178/250) |
PI-RADS Score 5 | 18.6% (22/118) | 19.1% (13/68) | 32.8% (21/64) | 22.4% (56/250) |
Location: | ||||
PZ | 45.3% (58/128) | 57.9% (44/76) | 48.7% (38/78) | 56.0% (140/250) |
TZ | 49.2% (63/128) | 28.9% (22/76) | 34.6% (27/78) | 44.8% (112/250) |
CZ | 0.8% (1/128) | 2.6% (2/76) | 0% (0/78) | 1.2% (3/250) |
AS | 4.7% (6/128) | 10.5% (8/76) | 16.7% (13/78) | 10.8% (27/250) |